The Asia Pacific Ingestible Sensors Market would witness market growth of 11.5% CAGR during the forecast period (2022-2028).
The equilibrium of gastric juice is vitally important. Important metrics to monitor in the stomach include pH, metabolite levels, electrolyte generation (such as bicarbonate), and enzymes. It is essential to visually examine the mucosal quality when searching for stomach ulcers and other illnesses. The screening for ulcer-causing bacteria, such as Helicobacter pylori, is an essential diagnostic procedure.
Analysis of feces (colonic content) is an essential diagnostic procedure. Moreover, infection (from viruses, parasites, or bacteria), inadequate nutrition absorption, and in severe situations cancer are among the problems that this examination can assist to identify. In addition to blood traces, the colonic content can be analyzed for the presence of lipids, proteins, and fibers. The electrolyte breakdown in the colon is also essential for determining its functioning.
Colonoscopies are necessary to assess the integrity of the colon mucosa in search of inflammation and lesions. Indicators of the health of the colon include butyrate, acetate, and propionate, in addition to other metabolites. The sequencing and analysis of the microbiome of this region are becoming more important for treating a variety of illnesses in the body, particularly those associated with the idea of a leaky colon. All of these evaluations can be easily performed through the ingestible sensor technology.
The ingestible sensors market in the region is estimated to witness broad expansion due to several factors, including the rising healthcare expenditure and the prevalence of chronic diseases. Significant expenditures in R&D by leading companies are also anticipated to contribute to regional growth. Countries, such as India, Japan, and China are anticipated to lead the region in the adoption of these diagnostic and therapeutic medical devices as a result of the high adoption of advanced technologies along with an increase in the number of market players operating within the region.
The China market dominated the Asia Pacific Ingestible Sensors Market by Country in 2021; thereby, achieving a market value of $125.2 Million by 2028. The Japan market is registering a CAGR of 10.8% during (2022 - 2028). Additionally, The India market would showcase CAGR of 12.2% during (2022 - 2028).
Based on Vertical, the market is segmented into Medical, Sports & Fitness and Others. Based on Component, the market is segmented into Sensor, Wearable Patch/Data Recorder and Software. Based on Sensor Type, the market is segmented into Temperature Senso, Image Sensor, pH Sensor and Pressure Sensor. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Ingestible Sensors Market is Projected to reach USD 1.5 Billion by 2028, at a CAGR of 10.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Check Cap Ltd., Dassault Systemes (Medidata Solutions, Inc.), etectRx™, Inc., H.Q., Inc., Otsuka Pharmaceutical Co., Ltd., CapsoVision, Inc., IntroMedic Co., Ltd. and Chongqing Jinshan Science and Technology Group Co., Ltd.
By Vertical
By Component
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
